Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

1(25.0%)

Phase 1

1(25.0%)

N/A

1(25.0%)

Phase 3

1(25.0%)

4Total

Phase 2(1)

Phase 1(1)

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04895540Unknown

South Asian Arrhythmogenic Cardiomyopathy Registry

Role: lead

NCT04588909Unknown

Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy

Role: lead

NCT04365647Completed

Intra-operative Variation in Size of Brain Tumors After Craniotomy

Role: lead

NCT02983721Not ApplicableCompleted

Trans Radial Versus Transfemoral Route for Coronary Angiography

Role: lead

NCT00553072Phase 3Completed

Magnesium Sulphate in Perinatal Asphyxia

Role: lead

NCT02002039Phase 2Completed

Neuroprotective Role of Erythropoietin in Perinatal Asphyxia

Role: lead

NCT01922700Completed

Effects of Pepper Gas Exposure in Non-combatant Bystanders.

Role: lead

NCT02040350Phase 1Completed

Is the WHO Recommended Dose of Pralidoxime Effective in the Treatment of Organophosphorus Poisoning?

Role: lead

All 8 trials loaded